MONTELUKAST

MONTELUKAST was reported 123348 times

MONTELUKAST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RIGHT ATRIAL HYPERTROPHY 59 0.5364
1 SENSITISATION 284 0.3742
2 EJECTION FRACTION 216 0.3718
3 TOTAL LUNG CAPACITY ABNORMAL 142 0.3650
4 PULMONARY VASCULITIS 174 0.3234
5 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 511 0.2504
6 CAPILLARITIS 65 0.2355
7 TOTAL LUNG CAPACITY INCREASED 64 0.2353
8 SPIROMETRY ABNORMAL 137 0.2291
9 MITE ALLERGY 149 0.2275
10 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 107 0.2046
11 OBSESSIVE-COMPULSIVE SYMPTOM 67 0.1816
12 DEFIANT BEHAVIOUR 55 0.1786
13 POLYCYSTIC OVARIES 273 0.1759
14 HUMAN RHINOVIRUS TEST POSITIVE 65 0.1743
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 150 0.1618
16 EPIDURAL LIPOMATOSIS 55 0.1599
17 MYCOTIC ALLERGY 136 0.1591
18 DUST ALLERGY 153 0.1560
19 VITAL CAPACITY DECREASED 69 0.1540
20 CHRONIC SPONTANEOUS URTICARIA 161 0.1388
21 TEMPERATURE REGULATION DISORDER 309 0.1386
22 SLEEP TERROR 572 0.1357
23 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 98 0.1337
24 FORCED EXPIRATORY VOLUME DECREASED 357 0.1259
25 BRONCHIAL WALL THICKENING 90 0.1252
26 NEUROPSYCHOLOGICAL SYMPTOMS 73 0.1211
27 PNEUMONIA HAEMOPHILUS 57 0.1173
28 RHINITIS ALLERGIC 512 0.1149
29 NASAL OEDEMA 207 0.1145
30 BLOOD IMMUNOGLOBULIN E INCREASED 271 0.1118
31 BODY TINEA 62 0.1107
32 RESPIRATORY SYMPTOM 311 0.1092
33 REVERSIBLE AIRWAYS OBSTRUCTION 54 0.1063
34 NEURITIS 159 0.1029
35 PULMONARY FUNCTION TEST ABNORMAL 155 0.0994
36 OBSTRUCTIVE AIRWAYS DISORDER 1106 0.0993
37 ASTHMATIC CRISIS 358 0.0979
38 CONJUNCTIVITIS ALLERGIC 145 0.0978
39 MAST CELL ACTIVATION SYNDROME 137 0.0976
40 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 67 0.0953
41 ALLERGIC GRANULOMATOUS ANGIITIS 73 0.0889
42 OBSTRUCTIVE SLEEP APNOEA SYNDROME 129 0.0884
43 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 54 0.0878
44 EJECTION FRACTION ABNORMAL 103 0.0840
45 FORCED VITAL CAPACITY DECREASED 54 0.0827
46 BRONCHIAL SECRETION RETENTION 104 0.0816
47 NEUROPSYCHIATRIC SYMPTOMS 73 0.0808
48 SINUSITIS FUNGAL 64 0.0798
49 EOSINOPHIL COUNT ABNORMAL 59 0.0790
50 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1258 0.0740
51 TOTAL LUNG CAPACITY DECREASED 115 0.0720
52 ASTHMA 8137 0.0719
53 FULL BLOOD COUNT ABNORMAL 756 0.0714
54 LUNG HYPERINFLATION 61 0.0709
55 FOOD ALLERGY 528 0.0683
56 ALLERGY TO ANIMAL 71 0.0666
57 RIGHT VENTRICULAR HYPERTROPHY 59 0.0653
58 SPUTUM DISCOLOURED 599 0.0631
59 NEPHRECTOMY 91 0.0612
60 WHEEZING 3630 0.0612
61 BRONCHIAL HYPERREACTIVITY 72 0.0599
62 NASAL POLYPS 295 0.0598
63 FOETAL DEATH 287 0.0553
64 NASAL DISCHARGE DISCOLOURATION 74 0.0536
65 RHONCHI 73 0.0528
66 SPUTUM INCREASED 113 0.0522
67 LUNG OPACITY 136 0.0516
68 INTRUSIVE THOUGHTS 59 0.0501
69 BRONCHIAL OBSTRUCTION 69 0.0491
70 CHRONIC SINUSITIS 184 0.0490
71 INFUSION SITE DISCHARGE 85 0.0484
72 IMPAIRED QUALITY OF LIFE 671 0.0466
73 BRONCHIECTASIS 309 0.0458
74 TIC 249 0.0456
75 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 240 0.0441
76 BREATH SOUNDS ABNORMAL 216 0.0438
77 RALES 243 0.0418
78 INHIBITORY DRUG INTERACTION 64 0.0404
79 SEASONAL ALLERGY 570 0.0402
80 DIASTOLIC DYSFUNCTION 124 0.0401
81 ADJUSTMENT DISORDER 52 0.0400
82 DYSPNOEA AT REST 108 0.0372
83 BRONCHIAL DISORDER 57 0.0366
84 NORMOCHROMIC NORMOCYTIC ANAEMIA 110 0.0366
85 MULTIPLE ALLERGIES 286 0.0364
86 AORTIC VALVE STENOSIS 65 0.0364
87 REBOUND ACID HYPERSECRETION 110 0.0363
88 NIGHTMARE 1235 0.0357
89 OBSTRUCTION 140 0.0350
90 SLEEP APNOEA SYNDROME 667 0.0349
91 BLOOD TEST ABNORMAL 485 0.0345
92 RHINITIS 278 0.0344
93 IMMUNODEFICIENCY 505 0.0338
94 PLEURITIC PAIN 93 0.0337
95 NEPHROGENIC ANAEMIA 156 0.0336
96 PULMONARY ALVEOLAR HAEMORRHAGE 184 0.0328
97 PRODUCTIVE COUGH 1553 0.0325
98 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1562 0.0325
99 INFUSION SITE HAEMORRHAGE 106 0.0322
100 COELIAC DISEASE 316 0.0322
101 PULMONARY FUNCTION TEST DECREASED 141 0.0322
102 HYPERPARATHYROIDISM SECONDARY 80 0.0319
103 NEUROLOGICAL SYMPTOM 181 0.0316
104 FEMALE GENITAL TRACT FISTULA 54 0.0316
105 INFECTION SUSCEPTIBILITY INCREASED 69 0.0315
106 INFUSION SITE BRUISING 68 0.0315
107 CYSTIC FIBROSIS 174 0.0314
108 INFUSION SITE PRURITUS 99 0.0313
109 EOSINOPHIL COUNT INCREASED 254 0.0304
110 BLOOD COUNT ABNORMAL 451 0.0297
111 OBSESSIVE THOUGHTS 53 0.0294
112 TONGUE BITING 60 0.0291
113 DEPRESSION SUICIDAL 100 0.0289
114 SELF-INJURIOUS IDEATION 121 0.0288
115 NASAL OBSTRUCTION 54 0.0288
116 OBSESSIVE-COMPULSIVE DISORDER 231 0.0288
117 SENSITIVITY TO WEATHER CHANGE 149 0.0283
118 MIDDLE INSOMNIA 527 0.0282
119 SOMNAMBULISM 185 0.0282
120 UPPER-AIRWAY COUGH SYNDROME 232 0.0281
121 CARPAL TUNNEL SYNDROME 394 0.0281
122 BURSITIS 341 0.0281
123 CHEST X-RAY ABNORMAL 86 0.0280
124 UPPER RESPIRATORY TRACT INFECTION 1296 0.0280
125 NEGATIVE THOUGHTS 80 0.0273
126 SECRETION DISCHARGE 339 0.0270
127 RESPIRATION ABNORMAL 182 0.0264
128 RESPIRATORY TRACT CONGESTION 419 0.0263
129 RESPIRATORY TRACT INFECTION 669 0.0257
130 ATTENTION DEFICIT HYPERACTIVITY DISORDER 108 0.0256
131 INCREASED BRONCHIAL SECRETION 65 0.0254
132 INFUSION SITE ERYTHEMA 212 0.0251
133 SINUS PAIN 58 0.0249
134 THROAT CLEARING 93 0.0248
135 SINUS OPERATION 58 0.0243
136 INFUSION SITE SWELLING 153 0.0243
137 DYSPNOEA EXERTIONAL 905 0.0240
138 SOCIAL AVOIDANT BEHAVIOUR 139 0.0240
139 AGGRESSION 1175 0.0235
140 BLOOD IMMUNOGLOBULIN G DECREASED 58 0.0234
141 ARTERIOSCLEROSIS CORONARY ARTERY 155 0.0234
142 JUVENILE IDIOPATHIC ARTHRITIS 57 0.0233
143 PULMONARY PAIN 68 0.0233
144 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1656 0.0233
145 VASCULITIS 269 0.0231
146 ENURESIS 93 0.0230
147 ANGER 770 0.0227
148 BLOOD PRESSURE SYSTOLIC INCREASED 442 0.0226
149 EOSINOPHILIC PNEUMONIA 71 0.0225
150 EOSINOPHILIA 394 0.0225
151 DEPRESSIVE SYMPTOM 79 0.0224
152 PRESCRIBED OVERDOSE 423 0.0218
153 BENIGN PROSTATIC HYPERPLASIA 112 0.0217
154 PHARYNGEAL SWELLING 212 0.0216
155 STEM CELL TRANSPLANT 54 0.0216
156 RESPIRATORY RATE INCREASED 190 0.0214
157 BLOOD PRESSURE DIASTOLIC ABNORMAL 53 0.0208
158 BRONCHOSPASM 297 0.0208
159 NASAL CONGESTION 1218 0.0207
160 RESPIRATORY SYNCYTIAL VIRUS INFECTION 180 0.0207
161 PSYCHOMOTOR HYPERACTIVITY 341 0.0205
162 NASAL DISORDER 54 0.0203
163 PULMONARY FIBROSIS 388 0.0202
164 SNORING 76 0.0201
165 SUICIDAL BEHAVIOUR 83 0.0199
166 HYPOTHYROIDISM 631 0.0197
167 CHRONIC GRAFT VERSUS HOST DISEASE 71 0.0196
168 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1013 0.0194
169 LOWER RESPIRATORY TRACT INFECTION 882 0.0194
170 GASTROOESOPHAGEAL REFLUX DISEASE 1559 0.0193
171 EMPHYSEMA 195 0.0193
172 BEHAVIOUR DISORDER 104 0.0192
173 FIBROMYALGIA 463 0.0190
174 PARANASAL SINUS DISCOMFORT 72 0.0190
175 CUSHINGOID 61 0.0190
176 SKIN PLAQUE 160 0.0189
177 PNEUMONIA VIRAL 59 0.0185
178 INFUSION SITE PAIN 238 0.0185
179 DYSPHEMIA 81 0.0185
180 COUGH 5169 0.0184
181 SLEEP DISORDER 1298 0.0184
182 PRODUCT ADMINISTRATION INTERRUPTED 144 0.0183
183 GLUCOSE TOLERANCE IMPAIRED 108 0.0182
184 MOOD ALTERED 491 0.0180
185 CHEST DISCOMFORT 1843 0.0180
186 HAEMOPTYSIS 499 0.0179
187 PULMONARY MASS 266 0.0178
188 DEPRESSED MOOD 939 0.0177
189 SCREAMING 113 0.0177
190 SINUS CONGESTION 238 0.0176
191 SCRATCH 185 0.0175
192 SINUSITIS 1790 0.0174
193 BRONCHITIS 1284 0.0173
194 BODY TEMPERATURE DECREASED 170 0.0173
195 SINUS DISORDER 341 0.0172
196 EMBOLISM VENOUS 52 0.0171
197 ABNORMAL BEHAVIOUR 676 0.0170
198 BLOOD CALCIUM INCREASED 149 0.0170
199 DECREASED INTEREST 100 0.0169
200 SNEEZING 380 0.0169
201 CHOKING SENSATION 93 0.0168
202 PERSONALITY CHANGE 156 0.0168
203 TEARFULNESS 72 0.0167
204 EXERCISE TOLERANCE DECREASED 95 0.0165
205 QUALITY OF LIFE DECREASED 221 0.0165
206 POOR QUALITY SLEEP 347 0.0161
207 HYPOXIA 566 0.0161
208 PARANASAL SINUS HYPERSECRETION 61 0.0160
209 BRAIN FOG 250 0.0159
210 ARTERIOSCLEROSIS 149 0.0158
211 PARANOIA 262 0.0152
212 OXYGEN SATURATION DECREASED 851 0.0151
213 INTERVERTEBRAL DISC DEGENERATION 140 0.0151
214 EAR PRURITUS 53 0.0151
215 CHRONIC KIDNEY DISEASE 1148 0.0151
216 DYSPNOEA 8512 0.0150
217 END STAGE RENAL DISEASE 274 0.0150
218 PRE-EXISTING CONDITION IMPROVED 93 0.0149
219 SKIN ABRASION 70 0.0148
220 ANGIOEDEMA 653 0.0147
221 LUNG DISORDER 723 0.0147
222 PERIORBITAL SWELLING 83 0.0147
223 GLOSSITIS 52 0.0146
224 RHINORRHOEA 939 0.0145
225 OCULAR DISCOMFORT 163 0.0145
226 URTICARIA 2410 0.0144
227 OEDEMA 773 0.0142
228 MOOD SWINGS 454 0.0142
229 FRUSTRATION TOLERANCE DECREASED 115 0.0142
230 MAJOR DEPRESSION 104 0.0142
231 OBESITY 226 0.0142
232 CRYING 514 0.0141
233 PULMONARY CONGESTION 186 0.0141
234 RASH ERYTHEMATOUS 674 0.0141
235 SYMPTOM RECURRENCE 84 0.0140
236 INITIAL INSOMNIA 144 0.0140
237 SWELLING OF EYELID 88 0.0140
238 ASPIRATION 153 0.0140
239 HIATUS HERNIA 180 0.0139
240 OROPHARYNGEAL DISCOMFORT 125 0.0138
241 CANDIDA INFECTION 231 0.0137
242 RHINOVIRUS INFECTION 53 0.0136
243 SPINAL STENOSIS 56 0.0136
244 LEFT VENTRICULAR HYPERTROPHY 58 0.0135
245 DECREASED ACTIVITY 145 0.0134
246 ANAPHYLACTIC REACTION 741 0.0134
247 PNEUMONIA 4339 0.0134
248 MOUTH SWELLING 77 0.0133
249 PNEUMONIA BACTERIAL 122 0.0133
250 PSYCHIATRIC SYMPTOM 98 0.0133
251 APPETITE DISORDER 88 0.0133
252 SARCOIDOSIS 63 0.0132
253 PROSTATOMEGALY 52 0.0132
254 RESPIRATORY ACIDOSIS 52 0.0132
255 PRODUCT DOSE OMISSION IN ERROR 374 0.0132
256 HORDEOLUM 57 0.0132
257 ABDOMINAL HERNIA 60 0.0131
258 FLUID RETENTION 669 0.0131
259 EAR INFECTION 350 0.0131
260 IMPAIRED GASTRIC EMPTYING 179 0.0131
261 HYPERVENTILATION 76 0.0131
262 NODULE 171 0.0131
263 INSURANCE ISSUE 199 0.0130
264 INFLUENZA 1444 0.0129
265 HYSTERECTOMY 112 0.0129
266 CONCUSSION 100 0.0129
267 SUICIDAL IDEATION 1174 0.0128
268 ANXIETY 3645 0.0128
269 FEELING OF DESPAIR 59 0.0126
270 PAPULE 89 0.0126
271 EAR PAIN 244 0.0125
272 DYSPHONIA 731 0.0125
273 CARDIAC MURMUR 108 0.0125
274 DERMATITIS ATOPIC 653 0.0124
275 EAR DISCOMFORT 127 0.0124
276 ASPHYXIA 101 0.0124
277 OROPHARYNGEAL PAIN 1139 0.0123
278 MOUTH HAEMORRHAGE 90 0.0123
279 PULMONARY THROMBOSIS 133 0.0122
280 ABNORMAL DREAMS 336 0.0122
281 ILLNESS 1239 0.0120
282 RESPIRATORY DISORDER 359 0.0120
283 CHOKING 234 0.0120
284 ECZEMA 627 0.0120
285 APHONIA 166 0.0119
286 ANOSMIA 172 0.0119
287 THINKING ABNORMAL 221 0.0118
288 PANIC ATTACK 432 0.0118
289 DERMATITIS CONTACT 135 0.0118
290 ROSACEA 55 0.0118
291 ORAL HERPES 229 0.0117
292 VITAMIN D DEFICIENCY 114 0.0117
293 HEREDITARY ANGIOEDEMA 125 0.0116
294 POST-TRAUMATIC STRESS DISORDER 78 0.0116
295 TEMPERATURE INTOLERANCE 120 0.0116
296 EYE PRURITUS 390 0.0116
297 NEPHROPATHY 108 0.0116
298 HALLUCINATION, AUDITORY 183 0.0115
299 CONCOMITANT DISEASE AGGRAVATED 71 0.0115
300 INFUSION RELATED REACTION 761 0.0115
301 SINUS HEADACHE 68 0.0114
302 GESTATIONAL DIABETES 54 0.0113
303 FACIAL PAIN 101 0.0113
304 HYPOGAMMAGLOBULINAEMIA 74 0.0113
305 DIVERTICULUM 80 0.0112
306 CONTRAINDICATED PRODUCT ADMINISTERED 340 0.0112
307 LIGAMENT SPRAIN 111 0.0112
308 DECREASED IMMUNE RESPONSIVENESS 110 0.0112
309 OSTEOPOROSIS 461 0.0112
310 LUNG INFECTION 174 0.0112
311 TOOTH ABSCESS 114 0.0112
312 RESPIRATORY DEPRESSION 137 0.0112
313 POLYP 73 0.0111
314 GOUT 200 0.0111
315 PHARYNGITIS 138 0.0111
316 ACUTE RESPIRATORY FAILURE 214 0.0111
317 DIZZINESS POSTURAL 107 0.0110
318 VIRAL INFECTION 366 0.0110
319 WEIGHT FLUCTUATION 115 0.0110
320 FLANK PAIN 102 0.0109
321 IRON DEFICIENCY ANAEMIA 100 0.0108
322 THROAT IRRITATION 486 0.0108
323 DEPRESSION 2458 0.0108
324 COVID-19 1880 0.0107
325 HYPERLIPIDAEMIA 128 0.0107
326 DISCOMFORT 653 0.0107
327 AFFECTIVE DISORDER 84 0.0107
328 BACTERIAL INFECTION 199 0.0107
329 LIP SWELLING 354 0.0106
330 SKIN SWELLING 92 0.0106
331 HYPERSENSITIVITY 1960 0.0105
332 PURPURA 93 0.0105
333 THROAT TIGHTNESS 284 0.0105
334 INTENTIONAL SELF-INJURY 212 0.0105
335 AFFECT LABILITY 100 0.0104
336 SWOLLEN TONGUE 323 0.0103
337 COVID-19 PNEUMONIA 122 0.0103
338 NASOPHARYNGITIS 1899 0.0103
339 INFUSION SITE EXTRAVASATION 64 0.0103
340 BURNING SENSATION 717 0.0102
341 NASAL DRYNESS 64 0.0102
342 EYE DISCHARGE 106 0.0102
343 DRY EYE 508 0.0102
344 INTENTIONAL DOSE OMISSION 290 0.0102
345 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 66 0.0102
346 GASTROENTERITIS VIRAL 183 0.0101
347 RETCHING 216 0.0101
348 IRRITABILITY 607 0.0101
349 HEART RATE INCREASED 999 0.0101
350 TRICUSPID VALVE INCOMPETENCE 80 0.0101
351 NEURALGIA 244 0.0100
352 BRUXISM 54 0.0100
353 BODY HEIGHT DECREASED 107 0.0100
354 ARTHROPOD BITE 74 0.0100
355 MICTURITION URGENCY 114 0.0100
356 SARS-COV-2 TEST POSITIVE 131 0.0099
357 ADRENAL INSUFFICIENCY 120 0.0099
358 TYPE 2 DIABETES MELLITUS 332 0.0099
359 BLOOD IRON DECREASED 117 0.0099
360 ATELECTASIS 95 0.0098
361 RENAL DISORDER 458 0.0098
362 SPINAL OPERATION 121 0.0098
363 AGITATION 719 0.0098
364 HALLUCINATION 737 0.0098
365 DRY THROAT 99 0.0097
366 HEPATIC ENZYME INCREASED 662 0.0097
367 CONJUNCTIVITIS 180 0.0097
368 TENDERNESS 101 0.0097
369 JOINT INJURY 206 0.0096
370 NERVE COMPRESSION 89 0.0096
371 PHARYNGITIS STREPTOCOCCAL 104 0.0096
372 PLEURISY 57 0.0096
373 HYPERTENSION 2032 0.0096
374 EYE PAIN 540 0.0096
375 EYE INFECTION 108 0.0096
376 SKIN LACERATION 104 0.0096
377 SKIN HAEMORRHAGE 141 0.0095
378 ANKLE FRACTURE 147 0.0095
379 PRODUCT USE IN UNAPPROVED INDICATION 2337 0.0094
380 FUNGAL INFECTION 314 0.0094
381 LACRIMATION INCREASED 284 0.0094
382 SKIN INFECTION 105 0.0094
383 DISTURBANCE IN ATTENTION 504 0.0093
384 BLOOD PRESSURE INCREASED 1425 0.0093
385 INSOMNIA 2472 0.0093
386 SKIN ATROPHY 53 0.0092
387 GLAUCOMA 177 0.0092
388 EXPOSURE VIA SKIN CONTACT 237 0.0091
389 EXPOSURE DURING PREGNANCY 567 0.0091
390 ABNORMAL LOSS OF WEIGHT 62 0.0091
391 RENAL INJURY 270 0.0091
392 CONTUSION 875 0.0091
393 POOR VENOUS ACCESS 94 0.0091
394 PARAESTHESIA ORAL 131 0.0091
395 MIGRAINE 863 0.0090
396 HAND FRACTURE 64 0.0090
397 CELLULITIS 455 0.0090
398 RESTLESS LEGS SYNDROME 164 0.0090
399 HYPERCHOLESTEROLAEMIA 87 0.0090
400 VITAMIN D DECREASED 77 0.0090
401 SUPRAVENTRICULAR TACHYCARDIA 86 0.0090
402 FEAR 241 0.0090
403 PRODUCT DISTRIBUTION ISSUE 83 0.0089
404 AUTOIMMUNE DISORDER 87 0.0089
405 MUSCULOSKELETAL CHEST PAIN 138 0.0089
406 DISEASE RECURRENCE 423 0.0089
407 PRODUCT DOSE OMISSION ISSUE 2614 0.0089
408 FEELING DRUNK 66 0.0089
409 PHOTOPHOBIA 167 0.0089
410 PERIPHERAL SWELLING 1366 0.0089
411 INFECTION 1281 0.0088
412 THERAPEUTIC RESPONSE SHORTENED 293 0.0088
413 INCREASED TENDENCY TO BRUISE 81 0.0088
414 SQUAMOUS CELL CARCINOMA OF SKIN 53 0.0088
415 SWELLING FACE 571 0.0088
416 OSTEOARTHRITIS 371 0.0087
417 PAROSMIA 66 0.0087
418 LIVER FUNCTION TEST INCREASED 187 0.0087
419 PRODUCT PRESCRIBING ERROR 207 0.0087
420 THERAPEUTIC RESPONSE DECREASED 521 0.0086
421 NASAL DISCOMFORT 68 0.0086
422 IMMUNE SYSTEM DISORDER 113 0.0086
423 OSTEOPENIA 130 0.0086
424 THIRST 153 0.0086
425 SENSITIVE SKIN 63 0.0085
426 BLOOD PRESSURE DIASTOLIC DECREASED 63 0.0085
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1533 0.0085
428 LIMB INJURY 231 0.0085
429 BOWEL MOVEMENT IRREGULARITY 65 0.0085
430 BIPOLAR DISORDER 92 0.0085
431 SKIN FISSURES 165 0.0084
432 EYE SWELLING 314 0.0084
433 MUSCLE STRAIN 73 0.0084
434 ORAL CANDIDIASIS 111 0.0084
435 PRURITUS 3235 0.0084
436 HEADACHE 5265 0.0084
437 INTENTIONAL PRODUCT MISUSE 735 0.0084
438 HALLUCINATION, VISUAL 177 0.0084
439 WRIST FRACTURE 100 0.0083
440 FORMICATION 58 0.0083
441 ROTATOR CUFF SYNDROME 107 0.0083
442 BLOOD POTASSIUM DECREASED 249 0.0083
443 PSEUDOMONAS INFECTION 71 0.0083
444 CHEST PAIN 1533 0.0083
445 HYPERHIDROSIS 1065 0.0083
446 JOINT SWELLING 994 0.0082
447 JOINT DISLOCATION 87 0.0082
448 CARDIAC FLUTTER 53 0.0082
449 NOCTURIA 99 0.0081
450 DRUG INTOLERANCE 786 0.0081
451 FEELING COLD 226 0.0081
452 DISSOCIATION 62 0.0081
453 CHOLELITHIASIS 265 0.0081
454 PNEUMOTHORAX 128 0.0081
455 HEPATIC STEATOSIS 150 0.0080
456 PETECHIAE 84 0.0080
457 BLOOD PRESSURE ABNORMAL 160 0.0080
458 LUNG INFILTRATION 71 0.0080
459 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 71 0.0080
460 FOOT FRACTURE 152 0.0080
461 DIVERTICULITIS 221 0.0080
462 MENTAL DISORDER 345 0.0079
463 PRODUCT SUBSTITUTION ISSUE 456 0.0079
464 CATARACT 471 0.0079
465 SWELLING 731 0.0078
466 BLOOD PRESSURE FLUCTUATION 187 0.0078
467 SENSORY DISTURBANCE 125 0.0078
468 INTERVERTEBRAL DISC PROTRUSION 170 0.0078
469 ATRIAL FLUTTER 62 0.0078
470 ASPERGILLUS INFECTION 51 0.0078
471 HERPES ZOSTER 446 0.0078
472 CONDITION AGGRAVATED 2360 0.0078
473 RESTLESSNESS 284 0.0078
474 FATIGUE 6033 0.0077
475 GASTROENTERITIS 113 0.0077
476 RIB FRACTURE 159 0.0077
477 GRIP STRENGTH DECREASED 68 0.0077
478 EMOTIONAL DISORDER 237 0.0077
479 TOOTH INFECTION 101 0.0077
480 EYE IRRITATION 440 0.0076
481 PYREXIA 2622 0.0076
482 RESPIRATORY DISTRESS 209 0.0076
483 CYSTITIS 241 0.0076
484 ANAL INCONTINENCE 68 0.0076
485 EPISTAXIS 565 0.0075
486 PRODUCT USE ISSUE 1415 0.0075
487 SCIATICA 120 0.0075
488 HEAD DISCOMFORT 133 0.0075
489 PRODUCT TASTE ABNORMAL 101 0.0075
490 AGEUSIA 186 0.0074
491 RASH PRURITIC 404 0.0074
492 PHOTOSENSITIVITY REACTION 123 0.0074
493 KIDNEY INFECTION 146 0.0074
494 RASH MACULAR 260 0.0074
495 THERAPY PARTIAL RESPONDER 116 0.0074
496 WEIGHT INCREASED 1660 0.0074
497 CARDIAC DISORDER 692 0.0074
498 DERMATITIS ALLERGIC 93 0.0074
499 BALANCE DISORDER 639 0.0074
500 MALAISE 3241 0.0074
501 IMMUNOSUPPRESSION 65 0.0074
502 BACK PAIN 1711 0.0074
503 BACK INJURY 80 0.0073
504 CONSTIPATION 1602 0.0073
505 OCULAR HYPERAEMIA 348 0.0073
506 OEDEMA PERIPHERAL 892 0.0073
507 RASH 3180 0.0073
508 RESPIRATORY FAILURE 531 0.0073
509 HYPERSOMNIA 208 0.0072
510 DRY MOUTH 588 0.0072
511 TREMOR 1201 0.0072
512 ARTHRITIS 568 0.0072
513 ACUTE KIDNEY INJURY 1105 0.0072
514 HAEMATOMA 187 0.0072
515 PALPITATIONS 845 0.0072
516 DERMATITIS 151 0.0072
517 BACK DISORDER 117 0.0072
518 URINARY TRACT INFECTION 1227 0.0072
519 EATING DISORDER 153 0.0072
520 BLOOD MAGNESIUM DECREASED 62 0.0072
521 SINUS TACHYCARDIA 102 0.0072
522 DYSPEPSIA 705 0.0072
523 SKIN DISORDER 239 0.0072
524 MUSCULOSKELETAL DISCOMFORT 123 0.0071
525 MEDICATION ERROR 396 0.0071
526 HYPERGLYCAEMIA 259 0.0071
527 HEART RATE IRREGULAR 160 0.0071
528 PERIPHERAL COLDNESS 97 0.0071
529 MYASTHENIA GRAVIS 57 0.0071
530 ERYTHEMA 1449 0.0070
531 NIGHT SWEATS 227 0.0070
532 GINGIVAL PAIN 56 0.0070
533 SKIN LESION 193 0.0070
534 BLOOD PRESSURE DECREASED 466 0.0070
535 POST PROCEDURAL INFECTION 57 0.0070
536 STAPHYLOCOCCAL INFECTION 231 0.0070
537 NECK PAIN 391 0.0070
538 SKIN DISCOLOURATION 321 0.0070
539 UPPER LIMB FRACTURE 139 0.0070
540 WEIGHT DECREASED 1944 0.0070
541 PULMONARY HYPERTENSION 145 0.0070
542 PSYCHOTIC DISORDER 205 0.0069
543 ORAL PAIN 155 0.0069
544 THERAPY INTERRUPTED 494 0.0069
545 TASTE DISORDER 140 0.0069
546 MUSCLE TWITCHING 159 0.0069
547 HOSPICE CARE 68 0.0069
548 VERTIGO 419 0.0069
549 PRODUCT DOSE OMISSION 448 0.0069
550 AMNESIA 446 0.0068
551 TOOTHACHE 124 0.0068
552 EYE DISORDER 225 0.0068
553 SCAB 78 0.0068
554 THROMBOSIS 550 0.0068
555 IMPAIRED WORK ABILITY 146 0.0068
556 ATRIAL FIBRILLATION 664 0.0068
557 MUSCLE SPASMS 1251 0.0068
558 FALL 2265 0.0068
559 KNEE ARTHROPLASTY 143 0.0068
560 TRANSAMINASES INCREASED 151 0.0068
561 APATHY 99 0.0068
562 CHROMATURIA 153 0.0068
563 ORAL DISCOMFORT 94 0.0068
564 THERAPY NON-RESPONDER 304 0.0068
565 PLATELET COUNT INCREASED 88 0.0067
566 BLADDER DISORDER 67 0.0067
567 GAIT INABILITY 225 0.0067
568 PSYCHOLOGICAL TRAUMA 58 0.0067
569 TENDONITIS 104 0.0067
570 ARTHRALGIA 2791 0.0067
571 PSORIASIS 875 0.0067
572 MACULAR DEGENERATION 80 0.0067
573 PARAESTHESIA 1051 0.0067
574 MUSCLE DISORDER 54 0.0067
575 FEELING HOT 408 0.0066
576 INTERNAL HAEMORRHAGE 76 0.0066
577 NEPHROLITHIASIS 305 0.0066
578 INTENTIONAL PRODUCT USE ISSUE 580 0.0066
579 PAIN IN EXTREMITY 1947 0.0066
580 EYE INFLAMMATION 63 0.0066
581 MEMORY IMPAIRMENT 907 0.0066
582 HYPOAESTHESIA 985 0.0066
583 RHEUMATOID ARTHRITIS 746 0.0066
584 LETHARGY 377 0.0065
585 PAIN 4020 0.0065
586 VOMITING 3074 0.0065
587 PROCEDURAL PAIN 181 0.0065
588 DIZZINESS 3243 0.0065
589 HOSPITALISATION 999 0.0065
590 PRESYNCOPE 158 0.0065
591 SALIVARY HYPERSECRETION 65 0.0065
592 PAIN IN JAW 184 0.0065
593 NERVOUSNESS 339 0.0065
594 SPINAL OSTEOARTHRITIS 57 0.0065
595 SURGERY 380 0.0065
596 DRUG EFFECT LESS THAN EXPECTED 96 0.0065
597 PRODUCT USE COMPLAINT 102 0.0065
598 HOT FLUSH 487 0.0065
599 VISION BLURRED 886 0.0064
600 MULTIPLE FRACTURES 106 0.0064
601 ABDOMINAL PAIN UPPER 1323 0.0064
602 MUSCULOSKELETAL STIFFNESS 562 0.0064
603 WHITE BLOOD CELL COUNT INCREASED 246 0.0064
604 RENAL FAILURE 849 0.0064
605 GASTRITIS 168 0.0064
606 INJECTION SITE PRURITUS 427 0.0064
607 PHARYNGEAL OEDEMA 98 0.0064
608 TREATMENT FAILURE 527 0.0064
609 FEEDING DISORDER 129 0.0064
610 TRANSIENT ISCHAEMIC ATTACK 214 0.0063
611 SPINAL FRACTURE 127 0.0063
612 DYSSTASIA 185 0.0063
613 FACIAL PARALYSIS 54 0.0063
614 LOCALISED INFECTION 153 0.0063
615 CHOLECYSTECTOMY 72 0.0063
616 LIMB DISCOMFORT 195 0.0063
617 FACE OEDEMA 106 0.0063
618 PSORIATIC ARTHROPATHY 255 0.0063
619 PRODUCT AVAILABILITY ISSUE 143 0.0063
620 MOBILITY DECREASED 451 0.0063
621 MYALGIA 1064 0.0063
622 GASTROINTESTINAL INFECTION 56 0.0062
623 INCONTINENCE 66 0.0062
624 TUBULOINTERSTITIAL NEPHRITIS 117 0.0062
625 ANHEDONIA 164 0.0062
626 WITHDRAWAL SYNDROME 261 0.0062
627 WOUND INFECTION 68 0.0062
628 HERNIA 120 0.0062
629 SPEECH DISORDER 324 0.0062
630 CARDIOMEGALY 76 0.0062
631 GAIT DISTURBANCE 1181 0.0062
632 SENSATION OF FOREIGN BODY 52 0.0062
633 INJECTION SITE URTICARIA 151 0.0061
634 PERICARDIAL EFFUSION 142 0.0061
635 ABDOMINAL DISCOMFORT 1030 0.0061
636 BODY TEMPERATURE INCREASED 125 0.0061
637 FEELING ABNORMAL 1465 0.0061
638 PRODUCT ODOUR ABNORMAL 64 0.0061
639 SOMNOLENCE 1229 0.0061
640 HEAD INJURY 193 0.0061
641 FULL BLOOD COUNT DECREASED 122 0.0060
642 THERAPY CESSATION 310 0.0060
643 MOUTH ULCERATION 127 0.0060
644 EXOSTOSIS 55 0.0060
645 IRRITABLE BOWEL SYNDROME 129 0.0060
646 ANAPHYLACTIC SHOCK 155 0.0060
647 TACHYCARDIA 534 0.0060
648 FAECES DISCOLOURED 130 0.0060
649 BONE PAIN 351 0.0060
650 CHILLS 702 0.0060
651 INCREASED APPETITE 114 0.0060
652 PNEUMONIA ASPIRATION 149 0.0060
653 APHASIA 180 0.0060
654 PULMONARY EMBOLISM 566 0.0059
655 NEUROPATHY PERIPHERAL 566 0.0059
656 HEART RATE DECREASED 208 0.0059
657 SPINAL DISORDER 56 0.0059
658 ASTHENIA 2222 0.0059
659 PLEURAL EFFUSION 359 0.0059
660 ABDOMINAL DISTENSION 614 0.0059
661 DEVICE DELIVERY SYSTEM ISSUE 161 0.0059
662 NAUSEA 4646 0.0059
663 MUSCLE TIGHTNESS 95 0.0059
664 ACCIDENT 70 0.0059
665 BLISTER 329 0.0059
666 MOVEMENT DISORDER 188 0.0058
667 HYPOACUSIS 252 0.0058
668 DIARRHOEA 3778 0.0058
669 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 100 0.0058
670 INFLUENZA LIKE ILLNESS 479 0.0058
671 POST PROCEDURAL COMPLICATION 111 0.0058
672 MANIA 95 0.0058
673 SKIN EXFOLIATION 487 0.0058
674 MUSCULAR WEAKNESS 653 0.0057
675 PULMONARY OEDEMA 257 0.0057
676 DECREASED APPETITE 1324 0.0057
677 DIPLOPIA 148 0.0057
678 CARDIOMYOPATHY 84 0.0057
679 DYSPHAGIA 536 0.0056
680 BLOOD URINE PRESENT 107 0.0056
681 HAIR COLOUR CHANGES 70 0.0056
682 HIP ARTHROPLASTY 86 0.0056
683 INJECTION SITE SWELLING 430 0.0056
684 INJECTION SITE DISCOMFORT 59 0.0056
685 URINARY INCONTINENCE 166 0.0056
686 HUNGER 78 0.0056
687 KNEE OPERATION 55 0.0056
688 FLATULENCE 317 0.0056
689 POLLAKIURIA 232 0.0056
690 INFLAMMATION 287 0.0056
691 DISORIENTATION 220 0.0055
692 INJECTION SITE RASH 170 0.0055
693 INABILITY TO AFFORD MEDICATION 55 0.0055
694 GASTROINTESTINAL DISORDER 496 0.0055
695 THROMBOCYTOPENIA 619 0.0055
696 ERUCTATION 107 0.0055
697 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 303 0.0055
698 SCAR 94 0.0055
699 THYROID DISORDER 84 0.0054
700 MALIGNANT MELANOMA 73 0.0054
701 COORDINATION ABNORMAL 76 0.0054
702 DRY SKIN 727 0.0054
703 ABDOMINAL PAIN 1266 0.0054
704 TENDON RUPTURE 67 0.0054
705 FOOT DEFORMITY 60 0.0054
706 RENAL TUBULAR NECROSIS 53 0.0054
707 THERAPY CHANGE 53 0.0054
708 ILL-DEFINED DISORDER 327 0.0054
709 DYSURIA 198 0.0054
710 PNEUMONITIS 146 0.0054
711 BLOOD SODIUM DECREASED 101 0.0054
712 TINNITUS 246 0.0053
713 MYOCARDITIS 61 0.0053
714 EYE HAEMORRHAGE 71 0.0053
715 HAIR TEXTURE ABNORMAL 71 0.0053
716 CONFUSIONAL STATE 855 0.0053
717 ADVERSE DRUG REACTION 475 0.0053
718 COLD SWEAT 93 0.0053
719 EJECTION FRACTION DECREASED 82 0.0053
720 CYST 65 0.0052
721 ORTHOSTATIC HYPOTENSION 91 0.0052
722 WOUND 146 0.0052
723 URINARY RETENTION 174 0.0052
724 LEUKOCYTOSIS 94 0.0052
725 HAEMATOCRIT DECREASED 103 0.0052
726 BLOOD POTASSIUM INCREASED 84 0.0052
727 THERAPEUTIC RESPONSE UNEXPECTED 232 0.0052
728 CARDIAC FAILURE CONGESTIVE 415 0.0052
729 HYPOPHAGIA 132 0.0052
730 BLOOD CALCIUM DECREASED 58 0.0052
731 PLASMA CELL MYELOMA 201 0.0051
732 DIABETES MELLITUS 392 0.0051
733 ANGINA PECTORIS 147 0.0051
734 INJECTION SITE BRUISING 407 0.0051
735 CYANOSIS 80 0.0051
736 LYMPHADENOPATHY 180 0.0051
737 INJECTION SITE PAIN 1549 0.0050
738 HYPOAESTHESIA ORAL 76 0.0050
739 OFF LABEL USE 4406 0.0050
740 INJECTION SITE IRRITATION 64 0.0050
741 ABNORMAL WEIGHT GAIN 62 0.0050
742 FLUSHING 510 0.0050
743 ECONOMIC PROBLEM 76 0.0050
744 RED BLOOD CELL COUNT DECREASED 143 0.0050
745 PRODUCT ADMINISTRATION ERROR 101 0.0050
746 TOOTH FRACTURE 55 0.0050
747 FEELING JITTERY 95 0.0050
748 DRUG INEFFECTIVE 6565 0.0050
749 MENTAL STATUS CHANGES 138 0.0050
750 DRUG INTERACTION 787 0.0050
751 OESOPHAGITIS 54 0.0049
752 GENERALISED OEDEMA 61 0.0049
753 MYDRIASIS 63 0.0049
754 TOOTH DISORDER 109 0.0049
755 PRURITUS GENERALISED 106 0.0049
756 DEAFNESS 128 0.0049
757 GALLBLADDER DISORDER 87 0.0049
758 BLOOD CREATININE INCREASED 317 0.0049
759 GASTROINTESTINAL PAIN 53 0.0048
760 CLOSTRIDIUM DIFFICILE INFECTION 105 0.0048
761 VISUAL IMPAIRMENT 596 0.0048
762 BLOOD CHOLESTEROL INCREASED 224 0.0048
763 NEOPLASM 55 0.0048
764 HYPOTENSION 959 0.0048
765 ULCER 76 0.0048
766 DEHYDRATION 633 0.0047
767 TOOTH EXTRACTION 59 0.0047
768 MADAROSIS 55 0.0047
769 SYNCOPE 474 0.0047
770 LOWER LIMB FRACTURE 91 0.0047
771 LABORATORY TEST ABNORMAL 139 0.0047
772 ADVERSE REACTION 62 0.0047
773 SEIZURE 536 0.0046
774 INJECTION SITE ERYTHEMA 574 0.0046
775 MUSCULOSKELETAL PAIN 242 0.0046
776 REBOUND EFFECT 52 0.0046
777 GLOSSODYNIA 103 0.0046
778 DYSARTHRIA 173 0.0046
779 SEPSIS 511 0.0046
780 ALOPECIA 899 0.0046
781 GASTRIC DISORDER 157 0.0046
782 JOINT STIFFNESS 120 0.0046
783 UNEVALUABLE EVENT 346 0.0046
784 TACHYPNOEA 62 0.0046
785 PANCREATITIS ACUTE 102 0.0045
786 DEVICE FAILURE 69 0.0045
787 DRUG-INDUCED LIVER INJURY 141 0.0045
788 HYPOKALAEMIA 207 0.0045
789 PALLOR 122 0.0045
790 INJECTION SITE DISCOLOURATION 56 0.0045
791 DYSKINESIA 182 0.0045
792 MUSCULOSKELETAL DISORDER 85 0.0045
793 HAEMORRHOIDS 87 0.0045
794 HIP FRACTURE 143 0.0044
795 ROAD TRAFFIC ACCIDENT 186 0.0044
796 DYSGEUSIA 330 0.0044
797 GENERAL PHYSICAL HEALTH DETERIORATION 513 0.0044
798 LOSS OF CONSCIOUSNESS 567 0.0044
799 SYSTEMIC LUPUS ERYTHEMATOSUS 157 0.0044
800 PRODUCT PRESCRIBING ISSUE 96 0.0044
801 ARTHROPATHY 244 0.0044
802 HYPOMAGNESAEMIA 61 0.0044
803 HYPONATRAEMIA 245 0.0043
804 PULMONARY ARTERIAL HYPERTENSION 63 0.0043
805 DELUSION 67 0.0043
806 THERAPEUTIC PRODUCT EFFECT DECREASED 193 0.0043
807 SUICIDE ATTEMPT 260 0.0043
808 INJECTION SITE REACTION 295 0.0043
809 RASH PAPULAR 96 0.0043
810 UPPER GASTROINTESTINAL HAEMORRHAGE 72 0.0043
811 BONE DENSITY DECREASED 134 0.0043
812 WHITE BLOOD CELL COUNT DECREASED 463 0.0043
813 HYPOKINESIA 62 0.0043
814 CARDIAC FAILURE 341 0.0042
815 LACTIC ACIDOSIS 137 0.0042
816 NEEDLE ISSUE 123 0.0042
817 STOMATITIS 256 0.0042
818 PRODUCT QUALITY ISSUE 569 0.0042
819 INTESTINAL OBSTRUCTION 156 0.0041
820 SKIN REACTION 58 0.0041
821 DEMENTIA 115 0.0041
822 C-REACTIVE PROTEIN INCREASED 149 0.0041
823 COGNITIVE DISORDER 190 0.0041
824 MATERNAL EXPOSURE DURING PREGNANCY 360 0.0040
825 HAEMATEMESIS 102 0.0040
826 EMOTIONAL DISTRESS 486 0.0040
827 SKIN CANCER 86 0.0040
828 DEEP VEIN THROMBOSIS 258 0.0040
829 INCORRECT PRODUCT ADMINISTRATION DURATION 86 0.0040
830 MENTAL IMPAIRMENT 96 0.0040
831 ANAEMIA 754 0.0039
832 SKIN ULCER 102 0.0039
833 PLATELET COUNT DECREASED 420 0.0039
834 HAEMOGLOBIN DECREASED 403 0.0039
835 RENAL IMPAIRMENT 329 0.0039
836 PARALYSIS 56 0.0039
837 PANCREATITIS 206 0.0039
838 GINGIVAL BLEEDING 53 0.0039
839 JOINT RANGE OF MOTION DECREASED 52 0.0039
840 PAIN OF SKIN 104 0.0039
841 COMPLICATION ASSOCIATED WITH DEVICE 56 0.0039
842 ARRHYTHMIA 182 0.0038
843 DEVICE RELATED INFECTION 59 0.0038
844 BLINDNESS UNILATERAL 54 0.0038
845 BLOOD GLUCOSE ABNORMAL 70 0.0038
846 CYTOKINE RELEASE SYNDROME 76 0.0038
847 DRUG ERUPTION 67 0.0038
848 LEUKOPENIA 189 0.0038
849 ELECTROCARDIOGRAM QT PROLONGED 135 0.0037
850 PRODUCT PREPARATION ERROR 77 0.0037
851 DISABILITY 74 0.0037
852 HAEMATURIA 128 0.0037
853 HYPERTHYROIDISM 54 0.0037
854 HEPATIC CIRRHOSIS 70 0.0037
855 HYPOCALCAEMIA 70 0.0037
856 TREATMENT NONCOMPLIANCE 202 0.0037
857 GASTRIC ULCER 70 0.0037
858 NEUTROPHIL COUNT DECREASED 150 0.0037
859 PRODUCT PHYSICAL ISSUE 74 0.0037
860 HAEMATOCHEZIA 202 0.0037
861 RECTAL HAEMORRHAGE 156 0.0036
862 INCORRECT DOSE ADMINISTERED 826 0.0036
863 IMPAIRED HEALING 118 0.0036
864 INTERSTITIAL LUNG DISEASE 173 0.0036
865 HYPOGLYCAEMIA 172 0.0035
866 DEVICE USE ISSUE 62 0.0035
867 INJECTION SITE MASS 130 0.0035
868 BONE DISORDER 64 0.0035
869 LIVER FUNCTION TEST ABNORMAL 102 0.0035
870 FEBRILE NEUTROPENIA 232 0.0035
871 INTERNATIONAL NORMALISED RATIO INCREASED 99 0.0035
872 UNDERDOSE 252 0.0034
873 CARDIAC ARREST 285 0.0034
874 GLYCOSYLATED HAEMOGLOBIN INCREASED 87 0.0034
875 GASTROINTESTINAL HAEMORRHAGE 288 0.0034
876 ACCIDENTAL EXPOSURE TO PRODUCT 355 0.0034
877 SKIN IRRITATION 156 0.0034
878 RASH GENERALISED 88 0.0034
879 BLOOD GLUCOSE DECREASED 163 0.0034
880 ABSCESS 54 0.0034
881 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 158 0.0034
882 NO ADVERSE EVENT 612 0.0034
883 BLOOD UREA INCREASED 56 0.0033
884 BASAL CELL CARCINOMA 52 0.0033
885 SEROTONIN SYNDROME 64 0.0033
886 LIVER DISORDER 144 0.0032
887 GENERALISED TONIC-CLONIC SEIZURE 53 0.0032
888 LUNG NEOPLASM MALIGNANT 131 0.0032
889 OVERDOSE 687 0.0032
890 HEPATITIS 81 0.0032
891 ADVERSE EVENT 291 0.0032
892 SEPTIC SHOCK 137 0.0031
893 SHOCK 72 0.0031
894 HEMIPARESIS 53 0.0031
895 CHOLESTASIS 60 0.0031
896 ASPARTATE AMINOTRANSFERASE INCREASED 163 0.0031
897 EXTRA DOSE ADMINISTERED 124 0.0031
898 COAGULOPATHY 51 0.0031
899 DEVICE DEFECTIVE 53 0.0031
900 DEVICE ISSUE 273 0.0030
901 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 615 0.0030
902 HAEMORRHAGE 316 0.0030
903 DEVICE MALFUNCTION 212 0.0030
904 ENCEPHALOPATHY 74 0.0030
905 DIABETES MELLITUS INADEQUATE CONTROL 53 0.0030
906 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0030
907 HYPERKALAEMIA 104 0.0030
908 ALANINE AMINOTRANSFERASE INCREASED 182 0.0030
909 SEDATION 77 0.0029
910 COLITIS 111 0.0029
911 ACNE 222 0.0029
912 HEPATOTOXICITY 65 0.0029
913 COMPLETED SUICIDE 243 0.0029
914 PRODUCT DISPENSING ERROR 63 0.0029
915 FREQUENT BOWEL MOVEMENTS 78 0.0029
916 CEREBROVASCULAR ACCIDENT 489 0.0029
917 PRESCRIBED UNDERDOSE 57 0.0029
918 ACUTE MYOCARDIAL INFARCTION 84 0.0028
919 DELIRIUM 98 0.0028
920 CORONARY ARTERY DISEASE 85 0.0028
921 ACTIVITIES OF DAILY LIVING IMPAIRED 55 0.0028
922 OSTEONECROSIS 91 0.0028
923 PRODUCT COMPLAINT 70 0.0028
924 BRADYCARDIA 146 0.0027
925 NEUTROPENIA 372 0.0027
926 FRACTURE 51 0.0027
927 NERVOUS SYSTEM DISORDER 84 0.0027
928 DRUG DOSE OMISSION 441 0.0027
929 INJECTION SITE WARMTH 54 0.0026
930 BLOOD ALKALINE PHOSPHATASE INCREASED 65 0.0026
931 SKIN BURNING SENSATION 187 0.0026
932 BLOOD BILIRUBIN INCREASED 70 0.0026
933 EXPIRED PRODUCT ADMINISTERED 86 0.0026
934 ALTERED STATE OF CONSCIOUSNESS 56 0.0026
935 BLOOD GLUCOSE INCREASED 485 0.0026
936 DEPRESSED LEVEL OF CONSCIOUSNESS 101 0.0026
937 BLINDNESS 104 0.0025
938 EPILEPSY 77 0.0025
939 FEMUR FRACTURE 78 0.0025
940 CEREBRAL HAEMORRHAGE 90 0.0025
941 DRUG EFFECT INCOMPLETE 91 0.0025
942 INJURY 176 0.0025
943 RESPIRATORY ARREST 69 0.0025
944 NEOPLASM MALIGNANT 164 0.0025
945 JAUNDICE 66 0.0025
946 HEPATIC FAILURE 73 0.0024
947 MULTIPLE SCLEROSIS RELAPSE 165 0.0024
948 MULTIPLE SCLEROSIS 115 0.0024
949 UNRESPONSIVE TO STIMULI 62 0.0024
950 INJECTION SITE HAEMORRHAGE 191 0.0024
951 DRUG DOSE OMISSION BY DEVICE 187 0.0024
952 METABOLIC ACIDOSIS 76 0.0024
953 DISEASE PROGRESSION 281 0.0024
954 STEVENS-JOHNSON SYNDROME 52 0.0023
955 COMA 109 0.0023
956 DRUG RESISTANCE 58 0.0023
957 ABDOMINAL PAIN LOWER 57 0.0023
958 ASCITES 66 0.0022
959 MULTIPLE ORGAN DYSFUNCTION SYNDROME 63 0.0022
960 BLOOD CREATINE PHOSPHOKINASE INCREASED 64 0.0022
961 ERECTILE DYSFUNCTION 57 0.0022
962 COLITIS ULCERATIVE 99 0.0022
963 DEATH 1878 0.0022
964 INCORRECT DOSE ADMINISTERED BY DEVICE 57 0.0022
965 DIABETIC KETOACIDOSIS 52 0.0022
966 DRUG EFFECT DECREASED 114 0.0021
967 MYOCARDIAL INFARCTION 357 0.0020
968 CARDIO-RESPIRATORY ARREST 85 0.0020
969 DEVICE LEAKAGE 88 0.0020
970 VISUAL ACUITY REDUCED 66 0.0020
971 HEPATIC FUNCTION ABNORMAL 74 0.0020
972 PANCYTOPENIA 110 0.0020
973 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 66 0.0020
974 RHABDOMYOLYSIS 80 0.0019
975 DEVICE USE ERROR 66 0.0019
976 ABORTION SPONTANEOUS 76 0.0019
977 DRUG ADMINISTRATION ERROR 58 0.0019
978 INTENTIONAL OVERDOSE 114 0.0018
979 DEVICE BREAKAGE 72 0.0018
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 124 0.0017
981 VAGINAL HAEMORRHAGE 75 0.0017
982 DRUG ABUSE 141 0.0017
983 PRODUCT STORAGE ERROR 147 0.0017
984 DEVICE DISLOCATION 73 0.0017
985 BREAST CANCER 145 0.0016
986 TOXICITY TO VARIOUS AGENTS 254 0.0015
987 FOETAL EXPOSURE DURING PREGNANCY 115 0.0014
988 DRUG DEPENDENCE 222 0.0014
989 CONVULSION 63 0.0011
990 MALIGNANT NEOPLASM PROGRESSION 93 0.0009
991 DEVICE DIFFICULT TO USE 59 0.0009
992 DRUG WITHDRAWAL SYNDROME 74 0.0008
993 PROSTATE CANCER 64 0.0008